Compound Summary
Compound Information
histamine
Compound Name: | histamine |
Compound CID: | 774 |
Synonyms: | histamine 51-45-6 2-(1H-imidazol-5-yl)ethanamine Ergamine 1H-Imidazole-4-ethanamine More... |
Iupac Name: | 2-(1H-imidazol-5-yl)ethanamine |
InChI: | InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8) |
InChIKey: | NTYJJOPFIAHURM-UHFFFAOYSA-N |
Canonical Smiles: | C1=C(NC=N1)CCN |
Isomeric Smiles: | C1=C(NC=N1)CCN |
Molecular Weight: | 111.15 |
Molecular Formula: | C5H9N3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
histamine
Molecular Weight: | 111.15 |
Molecular Formula: | C5H9N3 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 8 |
Complexity: | 64.7 |
Synonyms
histamine
| histamine | histamine |
|---|---|
histamine |
51-45-6 |
2-(1H-imidazol-5-yl)ethanamine |
Ergamine |
1H-Imidazole-4-ethanamine |
2-(4-Imidazolyl)ethylamine |
Ergotidine |
Eramin |
5-Imidazoleethylamine |
Theramine |
2-Imidazol-4-ylethylamine |
Free histamine |
2-(1H-Imidazol-4-yl)ethanamine |
65592-96-3 |
beta-Aminoethylimidazole |
Imidazole-4-ethylamine |
2-(1H-imidazol-4-yl)ethan-1-amine |
beta-Aminoethylglyoxaline |
Histamine Base |
4-(2-Aminoethyl)-1H-imidazole |
Istamina |
4-Imidazoleethylamine |
1H-Imidazole-5-ethanamine |
beta-Imidazolyl-4-ethylamine |
2-(3H-Imidazol-4-yl)-ethylamine |
Ethylamine, 2-imidazol-4-yl- |
Imidazole, 4-(2-aminoethyl)- |
L-histamine |
3Hhistamine |
beta-aminothethylglyoxaline |
NSC 33792 |
peremin |
CHEBI:18295 |
UNII-820484N8I3 |
CHEMBL90 |
MFCD00005210 |
2-imidazol-5-ylethylamine |
4-(2-Aminoethyl)imidazole |
Histamin |
MLS000069447 |
.beta.-Imidazolyl-4-ethylamine |
2-(1H-Imidazol-4-yl)ethylamine |
MFCD00128939 |
NSC-33792 |
Histamine USAN |
Istamina Italian |
NCGC00015513-04 |
SMR000059091 |
Histamine, Free Base |
820484N8I3 |
DSSTox_CID_3125 |
DSSTox_RID_76884 |
DSSTox_GSID_23125 |
2-(1H-imidazol-5-yl)ethylamine dihydrochloride |
2-(3H-imidazol-4-yl)ethanamine |
CAS-51-45-6 |
Histaminum (TN) |
Histamine (DCF) |
CCRIS 6535 |
HSDB 3338 |
EINECS 200-100-6 |
3h-histamine |
imido- |
L-Histamin base |
Racemic histamine |
1avn |
1qft |
ALBB-005968 |
Spectrum_000845 |
Opera_ID_1772 |
Spectrum2_000665 |
Spectrum3_000452 |
Spectrum4_000960 |
Spectrum5_000796 |
Lopac-H-7250 |
b-Imidazolyl-4-ethylamine |
.beta.-Aminoethylimidazole |
bmse000744 |
.beta.-Aminoethylglyoxaline |
Histamine, >=97.0% |
SCHEMBL2279 |
2-(4-Imidazolyl)ethanamine |
2-imidazol-4-yl-Ethylamine |
Lopac0_000595 |
WLN: T5M CNJ D2Z |
BSPBio_001117 |
BSPBio_002124 |
KBioGR_000457 |
KBioGR_001580 |
KBioSS_000457 |
KBioSS_001325 |
DivK1c_000308 |
Histamine, analytical standard |
SPBio_000729 |
(1H-imidazol-4-yl)ethylamine |
BDBM7966 |
GTPL1204 |
GTPL1247 |
DTXSID4023125 |
BCBcMAP01_000250 |
KBio1_000308 |
KBio2_000457 |
KBio2_001325 |
KBio2_003025 |
KBio2_003893 |
KBio2_005593 |
KBio2_006461 |
KBio3_000853 |
KBio3_000854 |
KBio3_001344 |
F411C768-A159-4FC0-A195-291A08BB03AA |
2-(1H-Imidazol-5-yl)ethylamine |
2-(3H-imidazol-4-yl)ethylamine |
NINDS_000308 |
Bio1_000487 |
Bio1_000976 |
Bio1_001465 |
Bio2_000389 |
Bio2_000869 |
HMS1362G19 |
HMS1792G19 |
HMS1990G19 |
HMS3403G19 |
HMS3743G03 |
HMS3885M14 |
ZINC388081 |
2-(1H-Imidazol-4-yl)-ethylamine |
AMY33457 |
HY-B1204 |
NSC33792 |
Tox21_110166 |
2-(1H-imidazol-4-yl)ethylamine |
2-(1H-Imidazol-4-yl)ethanamine # |
BBL004932 |
BDBM50121205 |
Histamine Dihydrochloride (Salt/Mix) |
s3968 |
SBB012708 |
STK346752 |
AKOS000274386 |
AKOS009158347 |
Histamine, base, >=97.0% (NT) |
Tox21_110166_1 |
CCG-204684 |
CS-4697 |
DB05381 |
FS-5386 |
MCULE-4970362785 |
SDCCGMLS-0066601.P001 |
SDCCGSBI-0050577.P005 |
IDI1_000308 |
IDI1_002144 |
s10979 |
SMP1_000151 |
NCGC00015513-01 |
NCGC00015513-02 |
NCGC00015513-03 |
NCGC00015513-05 |
NCGC00015513-06 |
NCGC00015513-07 |
NCGC00015513-08 |
NCGC00015513-09 |
NCGC00015513-10 |
NCGC00015513-11 |
NCGC00015513-25 |
NCGC00093371-02 |
NCGC00093371-03 |
NCGC00093371-04 |
NCGC00093371-05 |
AC-13185 |
BP-11484 |
Histamine, Free Base - CAS 51-45-6 |
ST073926 |
SY041787 |
SBI-0050577.P004 |
AM20100377 |
BB 0241907 |
FT-0627839 |
Y9749 |
Histamine, Vetec(TM) reagent grade, >=97% |
2631-EP2268638A1 |
2631-EP2269989A1 |
2631-EP2269990A1 |
2631-EP2270002A1 |
2631-EP2275420A1 |
2631-EP2277565A2 |
2631-EP2277566A2 |
2631-EP2277567A1 |
2631-EP2277568A2 |
2631-EP2277569A2 |
2631-EP2277570A2 |
2631-EP2277848A1 |
2631-EP2280001A1 |
2631-EP2281563A1 |
2631-EP2286811A1 |
2631-EP2287165A2 |
2631-EP2287166A2 |
2631-EP2292280A1 |
2631-EP2292619A1 |
2631-EP2292620A2 |
2631-EP2295409A1 |
2631-EP2295423A1 |
2631-EP2298734A2 |
2631-EP2298767A1 |
2631-EP2298772A1 |
2631-EP2298776A1 |
2631-EP2300422A1 |
2631-EP2301937A1 |
2631-EP2305260A1 |
2631-EP2305640A2 |
2631-EP2305648A1 |
2631-EP2305652A2 |
2631-EP2305668A1 |
2631-EP2305677A1 |
2631-EP2308873A1 |
2631-EP2311801A1 |
2631-EP2311802A1 |
2631-EP2311803A1 |
2631-EP2311831A1 |
2631-EP2314574A1 |
2631-EP2314587A1 |
2631-EP2316459A1 |
2631-EP2316824A1 |
2631-EP2316831A1 |
2631-EP2371814A1 |
C00388 |
D08040 |
F10913 |
Q61233 |
AB00053481_20 |
AB00053481_21 |
056H928 |
163355-EP2270002A1 |
163355-EP2284166A1 |
714I940 |
A828600 |
L000292 |
J-505349 |
Histamine, EuropePharmacopoeia (EP) Reference Standard |
F2173-0575 |
117932-92-0 |
Experimental Data
histamine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 1 | mM | -7 | S | N2 | 25643626 | Inactive | ||||||
| Caenorhabditis elegans | 10 | mM | -7 | S | N2 | 25643626 | Inactive | ||||||
| Caenorhabditis elegans | 0.1 | mM | 3 | NS | N2 | 25643626 | Inactive |
Experimental Data Visualization
histamine
Statistics Data
histamine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 3 | 1 | 3 |
Statistics Data Visualization
histamine
